Hirsch, Hans H.

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 3.

Walti, Laura N.; Mugglin, Catrina; Sidler, Daniel; Mombelli, Matteo; Manuel, Oriol; Hirsch, Hans H.; Khanna, Nina; Mueller, Nicolas; Berger, Christoph; Boggian, Katia; Garzoni, Christian; Neofytos, Dionysios; van Delden, Christian; Hirzel, Cédric; Transplant Cohort Study Stcs, Swiss (2020). Association of Antiviral Prophylaxis and Rituximab Use with Post-transplant Lymphoproliferative Disorders (PTLD): A Nationwide Cohort Study. (In Press). American journal of transplantation Wiley-Blackwell 10.1111/ajt.16423

Metzner, Karin J.; Scherrer, Alexandra U.; Von Wyl, Viktor; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Aubert, Vincent; Furrer, Hansjakob; Hirsch, Hans H.; Vernazza, Pietro L.; Cavassini, Matthias; Calmy, Alexandra; Bernasconi, Enos; Weber, Rainer; Günthard, Huldrych F. (2014). Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients. AIDS, 28(15), pp. 2231-2239. Lippincott Williams & Wilkins 10.1097/QAD.0000000000000397

Hirsch, Hans H.; Mohaupt, Markus; Klimkait, Thomas (2001). Prospective Monitoring of BK Virus Load after Discontinuing Sirolimus Treatment in a Renal Transplant Patient with BK Virus Nephropathy. Journal of infectious diseases, 184(11), pp. 1494-1495. The University of Chicago Press 10.1086/324425

This list was generated on Sun May 16 20:43:34 2021 CEST.
Provide Feedback